Authors


Evelyn Chan, MBBS, MSc

Latest:

Brain Capital: An Emerging Investment Opportunity

Brain Capital: a fresh approach to technologies and investing.


Meghan Quinn, MD, Lieutenant, US Navy

Latest:

VIP Medicine: A Double-Edged Sword

What happens when patients receive special treatment based on their rank or relationships? Two survivors share their stories.


Esther Schoenfeld, MD

Latest:

Issues in Civil Commitment: The Cases of Incarcerated Patients

There are several points along this pathway for a justice involved patient to be intercepted and diverted to mental health treatment.


Avigal Snir, PhD

Latest:

D-cycloserine for Anxiety Disorders: What Psychiatrists Need to Know

D-cycloserine may help patients with anxiety disorders, or it might make their anxiety worse. Find out how to use it safely.


Ziva D. Cooper, PhD

Latest:

Current Treatments for Cannabis Use Disorder

While there are no FDA-approved medications available for CUD, some studies show potential off-label utility in mitigating withdrawal and maintaining abstinence. Learn more in this CME article.


Amy Vyas, MD

Latest:

Shattered Self: Schizophrenia Suffering, Beyond Logic and Reason

How can looking at the suffering of patients with schizophrenia through a psychodynamic lens help clinicians develop effective interventions and treatment plans?


Deb York, MSN, PMHNP-BC, APRN, CCRA

Latest:

Supporting Mothers With Postpartum Depression and Promoting Culturally Sensitive Care

Panelists discuss how faster-acting treatments like zuranolone might improve patient outcomes and quality of life, the initial signs to monitor for assessing effectiveness, barriers to accessing such therapies in underserved populations and strategies to increase accessibility, approaches to ensuring safety while addressing distress in patients with intrusive thoughts, effective strategies for managing sleep issues in postpartum depression (PPD), advice for the psychiatry community when treating PPD, and how to tailor advice for clinicians working with underserved populations.


Gordon Friesen

Latest:

The Medical Slope of Assisted Death: From "Who May" to "Who Should"

How will the definition of assisted death (AD) as medical care impact its utilization?


Gillian Zambor

Latest:

Exploring Music Therapy

3 music therapists share information on their program and treatments.


Matthew Brams, MD

Latest:

Optimizing Treatment for ADHD

“What we’re striving to do is conquer the unmet needs that are still here with treating ADHD, especially from a medication standpoint.”


Gilbert A. Masterson, MD

Latest:

8 Neuropsychiatric Symptoms and Treatments of Huntington Disease

In approximately half of patients with Huntington disease, symptoms of depression, irritability/aggression, executive dysfunction, psychosis, cognitive decline, and dementia present long before progressive motor symptoms.


Annabelle M. Mournet

Latest:

Implementation Challenges of Universal Suicide Risk Screening in Adult Patients in General Medical and Surgical Settings

The authors share evidence-based guidance for patient safety that minimizes suicide risk in medical settings.


Tresha Gibbs, MD

Latest:

Mental Health Disparities Among Black Americans During the COVID-19 Pandemic

The COVID-19 pandemic has disproportionately affected people of color due to legal, social, and economic inequities.


Brendan J. Dunlop

Latest:

Risky Business: The Higher Risk of Nonsuicidal Self Injury in Bisexual Individuals

Bisexual individuals are at 4.5 to 6 higher risk of self harming than heterosexual individuals, according to this online study.


Hua-Bin Li, PhD

Latest:

Connections Between Food Additives and Psychiatric Disorders

What are the connections between what we eat and disorders such as anxiety and depression?


Jack Bigelow, MA

Latest:

The Psychology of Fraud, Episode 4: A Focus on the Human Side

In the final episode of this series, the experts share their conclusions and why examining the human side of fraud—in addition to the instruments of fraud—is key.


Gordon Lavigne, MEd, CEO of the Schizophrenia & Psychosis Action Alliance
Gordon Lavigne, MEd

Latest:

Advocacy Group Applaud Joint FDA Committee Proposed Changes to Clozapine REMS Requirements

Gordon Lavigne, MEd, CEO of the Schizophrenia & Psychosis Action Alliance, talk about the joint FDA committee's vote on clozapine REMS.


Jerry Kimbrough

Latest:

Coordinating EHR System Data Across Youth Justice Facilities and Reentry Programs: A Critical Bridge to Successful Transitions

Effective coordination of EHR system data between youth justice facilities and reentry programs can play a pivotal role in a youth’s successful reintegration into the community.


Debra Stultz, MD

Latest:

Narcolepsy Treatment Advice

In this custom video series, Debra Stultz, MD, and Haramandeep Singh, MD, share advice for community-based psychiatrists on the management of narcolepsy.


Hannah Phillips-Hall, MSN, PMHNP-BC

Latest:

Case-Based Psych Perspectives: Treating Schizophrenia in the Era of COVID-19

This article provides a summary of key points discussed in a Case-Based Psych Perspectives Series, shared by Bryce Reynolds, MD, and Hannah Phillips-Hall, MSN, PMHNP-BC.


Geetha Reddy, MD, MPH

Latest:

Evaluating Dispositional Capacity in Patients With Late-Life Hoarding Disorder

For older adults, hoarding disorder can have serious consequences. Examine this case study to learn more.


Gary Kenneth Hulse, BBSc, MBSc, PhD

Latest:

Cannabis in Pregnancy – Rejoinder, Exposition and Cautionary Tales

Cannabis use during pregnancy is associated with a host of negative outcomes.


Megan Maier, MD

Latest:

Creativity Outlets: The Clinician’s Battery for Recharging

The ambiguity of psychiatry naturally lends itself to a story, and creativity is all about telling a story.



Hugh Burke

Latest:

Changing the Way Climate Change Psychiatry Is Researched: A Medical Student Perspective

A recent study serves as a model for future studies and lists several implications for the future of climate change psychiatric research.


Sharna Jamadar, PhD

Latest:

Are There Sex Differences in Cognition and Does It Matter?

Learn more about key findings on sex differences in cognition, exploring the possible causes and implications for clinical practice.


Jennifer Sotsky, MD, MS

Latest:

Lyme Disease in Psychiatry: Controversies, Chronic Symptoms, and Recent Developments

In this CME article, learn more about the controversies surrounding Lyme disease diagnosis and treatment, and common neuropsychiatric presentations of and treatment options.


Jessica M. Pierce, MD, MSc

Latest:

Multidisciplinary Inpatient Care for Medically Compromised Youth and Young Adults With Eating Disorders

In this CME article, learn more about a protocolized approach to the hospital management of pediatric patients with severe malnutrition related to eating disorders, including the utilization of a multidisciplinary care team and structured psychoeducation materials for families.


Alia Al-Tayyib, PhD

Latest:

After COVID-19 and Beyond the Opioid Wave

Lessons from the opioid epidemic should be applied to cases of methamphetamine abuse.


René S. Kahn, MD, PhD

Latest:

AI's Role in Advancing Psychiatry

René S. Kahn, MD, PhD, discussed the potential artificial intelligence has to advance the field of psychiatry when diagnosing patients and allowing clinicians to focus on the clinical conversation.

© 2025 MJH Life Sciences

All rights reserved.